Forward Therapeutics
- Biotech or pharma, therapeutic R&D
Forward Therapeutics is a clinical-stage biopharmaceutical company advancing novel, oral small molecule therapies for inflammation-driven diseases, including autoimmune and neurodegenerative conditions. Built on a novel chemistry-first, structure-based design approach, Forward’s programs are engineered for selective targeting, improved safety, and real-world usability. Its lead candidate, FT751, is a TNFR1-selective oral TNF signaling inhibitor now in Phase 1 trials, with additional programs underway in systemic and CNS indications. For more information, visit Forward-Tx.com and follow the company on LinkedIn.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}